Category | Disorder | Pathophysiology | Core clinical features | Clues and distinguishing features from PD |
Prominent tremor | Essential tremor | Not well characterized | - Bilateral action tremor in upper extremities
- Often also involves head and/or voice
| - Tremor is not present at rest (unless tremor is severe)
- No involvement of face or legs
- Family history
- Relieved by alcohol
|
Atypical parkinsonian disorders | Dementia with Lewy bodies | Synucleinopathy | - Dementia
- Visual hallucinations
- Fluctuating cognition
- Parkinsonism
| - Dementia begins before or at the same time as motor symptoms
|
Multiple system atrophy | Synucleinopathy; oligodendroglial alpha-synuclein aggregation | - Parkinsonism and/or cerebellar dysfunction
- Autonomic failure
- Pyramidal signs
| - Poor response to levodopa
- Symmetric motor symptoms
- Early falls
- Relatively preserved cognitive function
- Nocturnal stridor
|
Progressive supranuclear palsy | Tauopathy; tau-positive deposits in neurons and glia of basal ganglia, brainstem, cerebellum, and cortex | - Gait disturbance with falls
- Ophthalmoparesis
- Parkinsonism
| - Poor response to levodopa
- Early falls
- No tremor
- Pseudobulbar affect
|
Corticobasal degeneration | Tauopathy; tau-positive deposits in neurons and glia of cortex and striatum | - Asymmetric movement disorder (limb rigidity, dystonia, and/or myoclonus)
- Orobuccal or limb apraxia
- Cortical sensory deficits
- Alien limb phenomenon
- Cognitive dysfunction
| - Poor response to levodopa
- Aphasia, apraxia, and cortical sensory loss
|
Other neurodegenerative disorders | Idiopathic and familial basal ganglia calcification | Calcium deposits in basal ganglia; multiple causative genes | - Parkinsonism
- Chorea
- Dystonia
- Cognitive impairment
- Ataxia
| - Basal ganglia calcification on CT
- Family history (autosomal dominant or recessive pattern)
|
Huntington disease | CAG repeat expansion in the HTT gene; toxic gain-of-function mechanism due to mutant huntingtin protein | - Chorea
- Psychiatric illness
- Dementia
- Parkinsonism more common with older age of onset
| - Abnormal eye movements
- Motor impersistence
- No tremor
- Family history
|
Frontotemporal dementia with parkinsonism | Tauopathy; pathogenic variant in the MAPT gene on chromosome 17 | - Frontotemporal dementia (usually behavioral variant)
- Parkinsonism
| - Family history (autosomal dominant pattern)
- Younger age of onset
- Early memory impairment
|
Spinocerebellar ataxia | >40 genetic causes | - Progressive cerebellar syndrome
- Variable oculomotor, retinal, pyramidal, extrapyramidal, sensory, and cognitive symptoms depending on gene defect
| - Younger age of onset
- Family history
|
Secondary parkinsonism | Causes | Examples |
Drug-induced | Antipsychotic agents, metoclopramide, prochlorperazine, tetrabenazine, valproic acid |
Vascular | Vascular parkinsonism, vascular dementia |
Toxic | Carbon disulfide, carbon monoxide, cyanide, MPTP, manganese, organic solvents |
Metabolic | Hypoparathyroidism, pseudohypoparathyroidism, chronic liver failure, extrapontine myelinolysis, end-stage kidney disease with diabetes, type 2 diabetes |
Structural | Normal pressure hydrocephalus, chronic subdural hematoma, tumors involving striatonigral circuits, head trauma |
Infectious | Encephalitis lethargica, HIV/AIDS, neurosyphilis, prion disease, progressive multifocal leukoencephalopathy, toxoplasmosis |
Genetic | Wilson disease, neurodegeneration with brain iron accumulation, neuroacanthocytosis |